Subsequent Events	9 Months Ended
Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 10. Subsequent Events The Company has evaluated its subsequent events from September 30, 2020 through the date these condensed consolidated financial statements were issued and has determined that there are no subsequent events requiring disclosure in these condensed consolidated financial statements other than the item noted below. Series D Warrants The Company issued 270,270 Series D Warrants in October 2015, which are exercisable into 540,540 shares of the Company’s common stock, with an exercise price of $8.75 and a term of five years, expiring on October 15, 2020. These warrants subsequently expired without being exercised. Increase in Authorized Shares of Common Stock On September 28, 2020, the Board approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 to 250,000,000 shares and recommended that the Company’s stockholders approve such amendment. Subsequently, on November 10, 2020 a special meeting of the Company’s stockholders was held where the amendment was approved by the stockholders. Following the special meeting and obtaining the requisite vote of the stockholders, the amendment was filed with the Delaware Secretary of State on November 10, 2020.

Subsequent Events

9 Months Ended

Sep. 30, 2020

Note 10. Subsequent Events

The Company has evaluated its subsequent events from September 30, 2020 through the date these condensed consolidated financial statements were issued and has determined that there are no subsequent events requiring disclosure in these condensed consolidated financial statements other than the item noted below.

Series D Warrants

The Company issued 270,270 Series D Warrants in October 2015, which are exercisable into 540,540 shares of the Company’s common stock, with an exercise price of $8.75 and a term of five years, expiring on October 15, 2020. These warrants subsequently expired without being exercised.

Increase in Authorized Shares of Common Stock

On September 28, 2020, the Board approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 to 250,000,000 shares and recommended that the Company’s stockholders approve such amendment. Subsequently, on November 10, 2020 a special meeting of the Company’s stockholders was held where the amendment was approved by the stockholders. Following the special meeting and obtaining the requisite vote of the stockholders, the amendment was filed with the Delaware Secretary of State on November 10, 2020.